Addex Therapeutics (ADXN) Other Non Operating Income: 2022-2025
Historic Other Non Operating Income for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to $8,041.
- Addex Therapeutics' Other Non Operating Income rose 100.00% to $8,041 in Q2 2025 from the same period last year, while for Jun 2025 it was -$55.3 billion, marking a year-over-year decrease of 208.04%. This contributed to the annual value of $19,813 for FY2024, which is 105.61% up from last year.
- According to the latest figures from Q2 2025, Addex Therapeutics' Other Non Operating Income is $8,041, which was up 100.00% from -$20.7 billion recorded in Q1 2025.
- Addex Therapeutics' Other Non Operating Income's 5-year high stood at $52.6 billion during Q1 2024, with a 5-year trough of -$42.0 billion in Q1 2022.
- Over the past 3 years, Addex Therapeutics' median Other Non Operating Income value was -$177,742 (recorded in 2023), while the average stood at -$3.2 billion.
- Per our database at Business Quant, Addex Therapeutics' Other Non Operating Income surged by 441,774,717.36% in 2023 and then slumped by 19,711,801.14% in 2024.
- Addex Therapeutics' Other Non Operating Income (Quarterly) stood at -$176,837 in 2022, then declined by 14.30% to -$202,118 in 2023, then skyrocketed by 116.06% to $32,453 in 2024, then soared by 100.00% to $8,041 in 2025.
- Its last three reported values are $8,041 in Q2 2025, -$20.7 billion for Q1 2025, and $32,453 during Q4 2024.